The company's performance remains strong on an annual basis, with accumulated revenue from January through August 2026 rising 22% to SEK 2,464.8 million. Regional results reveal a stark contrast in market health. North America continues to act as a primary growth engine, surging 61% to SEK 63 million for the month. Central Europe also delivered robust results, climbing 18% to SEK 85.3 million.
Zinzino Reports 15% Revenue Growth in August
Zinzino Group saw its total revenue climb 15% in August, reaching SEK 282.2 million compared to SEK 245.9 million in the same period last year. While core sales markets fueled this momentum with a 16% increase, external sales from subsidiary Faun Pharma dipped to SEK 1.3 million.
Conversely, performance in the Nordic and Baltic regions trended downward. Sales in the Nordics fell 13% to SEK 23.6 million, while the Baltic market saw a 22% decline to SEK 7.6 million. Eastern Europe also faced headwinds, with revenue dropping 17% to SEK 23.8 million. Despite these regional contractions, the group’s expansion in South America—which grew 79%—and consistent gains in the Asia-Pacific region helped offset local volatility, keeping the overall trajectory positive for the Gothenburg-based firm.
Comments (0)
No comments yet. Be the first!